| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 239.641 | 231.478 | 245.510 | 201.764 | 232.471 | 233.629 | 217.051 | 216.485 | 233.376 | 229.069 |
| Total Income - EUR | 244.103 | 232.332 | 247.143 | 211.460 | 236.450 | 234.986 | 218.469 | 217.935 | 236.829 | 235.317 |
| Total Expenses - EUR | 240.524 | 229.382 | 242.963 | 204.598 | 229.183 | 227.406 | 211.608 | 214.099 | 232.866 | 229.187 |
| Gross Profit/Loss - EUR | 3.580 | 2.950 | 4.180 | 6.862 | 7.268 | 7.581 | 6.861 | 3.836 | 3.964 | 6.131 |
| Net Profit/Loss - EUR | 3.101 | 2.194 | 1.764 | 4.734 | 4.898 | 5.336 | 5.080 | 1.700 | 1.596 | 220 |
| Employees | 5 | 4 | 4 | 4 | 3 | 2 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Virolex Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.308 | 7.142 | 5.890 | 4.956 | 4.050 | 3.179 | 2.331 | 1.559 | 777 | 0 |
| Current Assets | 25.531 | 30.187 | 14.008 | 38.769 | 28.908 | 20.215 | 18.303 | 18.600 | 25.097 | 17.256 |
| Inventories | 19.522 | 24.156 | 9.343 | 34.970 | 26.886 | 13.366 | 15.475 | 16.720 | 19.662 | 12.533 |
| Receivables | 766 | 794 | 1.916 | 1.923 | 210 | 2.335 | 814 | 1.004 | 1.277 | 275 |
| Cash | 5.242 | 5.236 | 2.749 | 1.875 | 1.811 | 4.514 | 2.014 | 876 | 4.157 | 4.448 |
| Shareholders Funds | -2.380 | -162 | 1.884 | 6.583 | 11.354 | 16.212 | 5.250 | 1.975 | 3.565 | 2.178 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.218 | 37.490 | 18.014 | 37.142 | 21.603 | 7.182 | 15.384 | 18.184 | 22.309 | 15.079 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Virolex Com S.r.l.